BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) shares dropped 0.9% during mid-day trading on Tuesday . The stock traded as low as $10.20 and last traded at $10.2160. 1,302 shares were traded during mid-day trading, a decline of 55% from the average session volume of 2,874 shares. The stock had previously closed at $10.31.
BioSyent Price Performance
The stock’s fifty day simple moving average is $10.20 and its 200 day simple moving average is $10.28.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Articles
- Five stocks we like better than BioSyent
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
